Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Lloyd

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 9, 2008
A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapineLinda M Davies, Thomas R E Barnes, Peter B Jones, et al.
Royal Society Open Science|December 21, 2023
Exploring the relationships between psychological variables and loot box engagement, part 1: pre-registered hypothesesJames Close, Stuart Gordon Spicer, Laura Louise Nicklin, et al.
Royal Society Open Science|January 5, 2024
Exploring the relationships between psychological variables and loot box engagement, part 2: exploratory analyses of complex relationshipsStuart Gordon Spicer, James Close, Laura Louise Nicklin, et al.
Journal of Clinical Medicine|December 24, 2021
Development and Validation of the RAFFLE: A Measure of Reasons and Facilitators for Loot Box EngagementJoanne Lloyd, Laura Louise Nicklin, Stuart Gordon Spicer, et al.
BMJ Open|July 25, 2019
Longitudinal evaluation of a countywide alternative to the Quality and Outcomes Framework in UK General Practice aimed at improving Person Centred Coordinated CareJames Close, Ben Fosh, Hannah Wheat, et al.
Schizophrenia Bulletin|March 17, 2006
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophreniaShôn W Lewis, Thomas R E Barnes, Linda Davies, et al.
Archives of General Psychiatry|October 4, 2006
Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)Peter B Jones, Thomas R E Barnes, Linda Davies, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 9, 2008
A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapineLinda M Davies, Thomas R E Barnes, Peter B Jones, et al.
Royal Society Open Science|December 21, 2023
Exploring the relationships between psychological variables and loot box engagement, part 1: pre-registered hypothesesJames Close, Stuart Gordon Spicer, Laura Louise Nicklin, et al.
Royal Society Open Science|January 5, 2024
Exploring the relationships between psychological variables and loot box engagement, part 2: exploratory analyses of complex relationshipsStuart Gordon Spicer, James Close, Laura Louise Nicklin, et al.
Journal of Clinical Medicine|December 24, 2021
Development and Validation of the RAFFLE: A Measure of Reasons and Facilitators for Loot Box EngagementJoanne Lloyd, Laura Louise Nicklin, Stuart Gordon Spicer, et al.
BMJ Open|July 25, 2019
Longitudinal evaluation of a countywide alternative to the Quality and Outcomes Framework in UK General Practice aimed at improving Person Centred Coordinated CareJames Close, Ben Fosh, Hannah Wheat, et al.
Schizophrenia Bulletin|March 17, 2006
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophreniaShôn W Lewis, Thomas R E Barnes, Linda Davies, et al.
Archives of General Psychiatry|October 4, 2006
Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)Peter B Jones, Thomas R E Barnes, Linda Davies, et al.
Pageof 5